Healthtech platform, Medikabazaar, declared that it had raised $75 million in its Series C funding led by Creagis and CDC Group. The existing investors, including Ackermans & van Haaren (AvH), HealthQuad Advisors Private Limited, Rebright Partners, Kois Holdings, and Sumitomo Mitsui Financial Group, also participated in the round. The funds will deepen the company’s digital capabilities, grow the supply ecosystem, technology-driven distribution channels and provide a more extensive range of quality medical supplies over geographical regions.

• Cabinet Clears PM Dhan-Dhaanya Scheme to Boost 100 Agri Districts, Aid 1.7 Cr Farmers
• UK Inflation Surges Unexpectedly Amid Tax Hikes
• Biocon Hits 52-Week High After USFDA Nod for Key Diabetes Drug, Shares Up 1%
• Shilpa Medicare Jumps 5% After Bengaluru Unit Clears US FDA Inspection
• PVR INOX Drops 1% as Karnataka Plans Cap on Movie Ticket Prices

“We are thrilled to welcome Creagis and the CDC Group on board as investors. We are fascinated by the digital transformation track record of Creaegis and are trying to create a technology-driven platform assisting the healthcare ecosystem. The investment will let us improve our international operations and strengthen our presence in the B2B health tech industry,” Vivek Tiwari, Founder and Chief Executive Officer of Medikabazaar said. “With over 100,000 medical institutions, above 150,000 medical professionals, and over 15,000 seller partners, we are trying for a 300 per cent growth in FY22,” Tiwari added.